Bio Path Holdings Stock Price Prediction
| BPTH Stock | USD 0.06 0 2.17% |
Momentum 43
Sell Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Bio Path based on different types of headlines from major news networks to social media. Using Bio Path hype-based prediction, you can estimate the value of Bio Path Holdings from the perspective of Bio Path response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Bio Path. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Bio Path to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Bio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bio Path after-hype prediction price | USD 0.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bio |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Path After-Hype Price Prediction Density Analysis
As far as predicting the price of Bio Path at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio Path or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Bio Path, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bio Path Estimiated After-Hype Price Volatility
In the context of predicting Bio Path's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio Path's historical news coverage. Bio Path's after-hype downside and upside margins for the prediction period are 0.00 and 10.07, respectively. We have considered Bio Path's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bio Path is out of control at this time. Analysis and calculation of next after-hype price of Bio Path Holdings is based on 3 months time horizon.
Bio Path OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Bio Path is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Path backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio Path, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 10.10 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.06 | 0.06 | 0.00 |
|
Bio Path Hype Timeline
Bio Path Holdings is currently traded for 0.06. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bio is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.2%. %. The volatility of related hype on Bio Path is about 0.0%, with the expected price after the next announcement by competition of 0.06. The company recorded a loss per share of 8.34. Bio Path Holdings last dividend was issued on the 18th of January 2019. The entity had 1:20 split on the 23rd of February 2024. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Bio Path Basic Forecasting Models to cross-verify your projections.Bio Path Related Hype Analysis
Having access to credible news sources related to Bio Path's direct competition is more important than ever and may enhance your ability to predict Bio Path's future price movements. Getting to know how Bio Path's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio Path may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORGS | Orgenesis | 0.00 | 0 per month | 39.49 | 0.34 | 433.33 | (78.75) | 711.85 | |
| EMMA | Emmaus Life Sciences | 0.00 | 0 per month | 7.36 | 0.07 | 27.59 | (15.45) | 64.24 | |
| SQZB | SQZ Biotechnologies | 0.00 | 0 per month | 0.00 | (0.02) | 7.69 | (9.80) | 50.43 | |
| HXBM | Helix BioMedix | 0.00 | 0 per month | 0.00 | (0.21) | 0.00 | 0.00 | 25.93 | |
| IDCN | Indocan Resources | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PAIOF | Paion AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ELLXF | Elixinol Global | 0.00 | 0 per month | 30.44 | 0.27 | 222.22 | (64.47) | 322.27 | |
| YECO | Yulong Eco Materials | 0.00 | 0 per month | 0.00 | (0.02) | 0.00 | 0.00 | 42.46 | |
| UNBX | Unity Biotechnology | 0.00 | 0 per month | 11.01 | 0 | 22.58 | (17.00) | 87.87 | |
| VIBEF | Vibe Growth | 0.00 | 0 per month | 8.54 | 0.01 | 17.50 | (19.35) | 110.48 |
Bio Path Additional Predictive Modules
Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bio Path Predictive Indicators
The successful prediction of Bio Path stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bio Path Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bio Path based on analysis of Bio Path hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bio Path's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bio Path's related companies.
Story Coverage note for Bio Path
The number of cover stories for Bio Path depends on current market conditions and Bio Path's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bio Path is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bio Path's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bio Path Short Properties
Bio Path's future price predictability will typically decrease when Bio Path's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bio Path Holdings often depends not only on the future outlook of the potential Bio Path's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Path's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 478 K | |
| Cash And Short Term Investments | 1.1 M |
Complementary Tools for Bio OTC Stock analysis
When running Bio Path's price analysis, check to measure Bio Path's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Path is operating at the current time. Most of Bio Path's value examination focuses on studying past and present price action to predict the probability of Bio Path's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Path's price. Additionally, you may evaluate how the addition of Bio Path to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |